Xenon Pharmaceuticals, Inc. (XENE)
57.38
-1.21
(-2.07%)
USD |
NASDAQ |
May 07, 15:22
Xenon Pharmaceuticals SG&A Expense (TTM) : 79.63M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 101.79M |
| Edesa Biotech, Inc. | 4.581M |
| Lexaria Bioscience Corp. | 4.086M |
| Sirona Biochem Corp. | -- |
| ProMIS Neurosciences, Inc. | 6.788M |